Association between Systemic Immune-Inflammation Index and female breast cancer based on NHANES data (2001-2018): A cross-sectional study.

ABSTRACT: Worldwide cancer statistics have shown that breast cancer dominates female cancer incidence and remains a leading cause of death. The Systemic Immune-Inflammation Index (SII) is a new prognostic indicator of systemic inflammation used to assess systemic immune-inflammatory response levels in the human body. It is associated with the prognosis of various diseases, such as malignant tumors, cardiovascular diseases, and autoimmune diseases. Although SII offers valuable information for diagnosing and predicting the risk of female breast cancer (FBC), the association between SII and FBC has not yet been analyzed. Therefore, the relationship between SII and FBC was investigated in this study. Multivariate logistic regression, model fit assessment using Akaike Information Criterion (AIC) and Baye

SUBMITTER: Xiong J 

PROVIDER: S-EPMC12410753 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature